Brokerages Set Tenet Healthcare Corporation (NYSE:THC) Price Target at $244.84

Shares of Tenet Healthcare Corporation (NYSE:THC) have been given an average recommendation of “Moderate Buy” by the twenty-one brokerages that are covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and seventeen have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $246.4737.

Several research analysts recently commented on THC shares. Morgan Stanley set a $254.00 price target on Tenet Healthcare in a research note on Friday, May 1st. Stephens dropped their price objective on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. TD Cowen reduced their target price on Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Wells Fargo & Company raised their price target on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Finally, Royal Bank Of Canada cut their price target on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a report on Friday, May 1st.

Insider Buying and Selling at Tenet Healthcare

In related news, Director Nadja West sold 3,000 shares of the stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the sale, the director owned 24,805 shares in the company, valued at $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the sale, the director owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.97% of the stock is owned by insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. NewEdge Advisors LLC grew its holdings in Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after acquiring an additional 166 shares during the period. Jones Financial Companies Lllp boosted its position in shares of Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after purchasing an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC acquired a new position in shares of Tenet Healthcare in the 2nd quarter worth approximately $290,000. Quantbot Technologies LP bought a new stake in shares of Tenet Healthcare in the 2nd quarter worth approximately $65,000. Finally, Amundi lifted its stake in Tenet Healthcare by 4,207.8% during the second quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after purchasing an additional 26,383 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Performance

Tenet Healthcare stock opened at $233.10 on Thursday. The firm has a market capitalization of $20.08 billion, a PE ratio of 8.99, a price-to-earnings-growth ratio of 1.93 and a beta of 1.27. Tenet Healthcare has a one year low of $146.60 and a one year high of $247.21. The stock’s 50 day moving average price is $185.16 and its 200 day moving average price is $197.62. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Friday, July 24th. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 27.17%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the firm posted $4.02 earnings per share. As a group, sell-side analysts expect that Tenet Healthcare will post 21 EPS for the current fiscal year.

Key Stories Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet beat Q2 expectations by a wide margin, reporting $6.12 EPS versus estimates around $4.26, while revenue of $6.04 billion also came in above forecasts. The company cited strong same-store revenue growth and effective expense management. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Management raised FY 2026 EPS guidance to $20.30-$21.69, well above prior Street expectations, signaling that the earnings beat may not be a one-quarter event. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Investor enthusiasm was further supported by commentary highlighting hospital growth, expense control, and M&A momentum, with multiple reports describing the quarter as a “blockbuster” and noting the stock’s strong response. Tenet’s Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade
• Neutral Sentiment: Tenet’s earnings call transcript and presentation may provide more detail on the quarter and outlook, but the main stock driver today appears to be the earnings beat and guidance increase rather than any new strategic surprise. Tenet Healthcare Corporation (THC) Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Media coverage also noted broader strength in hospital stocks, which may be adding to the move in Tenet Healthcare (THC). Why Tenet Healthcare Stock Is Soaring Today

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.